CClinicalTrials.gg
CompletedNCT06742983Updated Jan 22, 2026

Healing Efficacy of Isobutyl Cyanoacrylate High Viscous Solution in Treatment of Traumatic Ulcer in Children

An interventional study of Isobutyl cyanoacrylate and Chlorhexidine (0.2%) in Ulcer, sponsored by Suez Canal University. Completed at 1 site in Egypt. Open to participants aged 4 Years to 8 Years. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by Suez Canal University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Aug 2023, registered Dec 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
4 Years to 8 Years
Sex
All
01

Study summary

30 children with traumatic oral ulcer that will be divided into equal three groups. Group A (Isobutyl cyanoacrylate) includes children will be treated with isobutyl cyanoacrylate high viscous solution only once during the treatment episode, group B (control positive) includes children will be treated chlorohexidine gel (0.2%) twice daily and group C (control negative) includes children will be treated with normal saline five times per day. Clinical follow up will be done by assessment of pain perception, photographs of the ulcer will be recorded by using digital camera and measurement of ulcer size in the 1st ,5th and 9th days after treatment

Read the detailed description

Thirty children will be randomly and equally allocated into three groups, by throwing a dice (1\&4 for group A, 2\&5 for group B and 3\&6 for group C). 10 for each group as follows: -

  • Group A (Isobutyl cyanoacrylate): 10 children will be treated with isobutyl cyanoacrylate high viscous solution will be applied on the ulcer site.
  • Group B (control positive): 10 children will be treated with chlorhexidine (0.2%) gel twice daily for 9 days.
  • Group C (control negative): 10 children will be treated with normal saline will be applied on the ulcer site 5 times per day.

    • Children will be examined before treatment to assess pain by using Children's International Mucositis Evaluation Scale (ChIMES) and measure ulcer size by periodontal probe. Then apply different treatments of each group
    • All patients in both groups will be instructed to avoid eating or drinking for at least half an hour after oral administration of the oral gel.
    • All patients can be given oral analgesics (paracetamol) if needed to decrease pain severity.
    • The size of the ulcers, change in pain severity will be assessed on the 1st, 5th and 9th days after using isobutyl cyanoacrylate high viscous solution and chlorhexidine (0.2%) gel.

Assessment of pain will be performed using Children's International Mucositis Evaluation Scale (ChIMES) will be used for pain assessment

  1. Photographs of the ulcers will be recorded with a digital camera at 1st, 5th and 9th days.
  2. Measurement of ulcer size by using a periodontal probe
02

Conditions studied

  • Ulcer

Browse trials for

Keywords

  • ulcer
  • chlorhexidine
  • Isobutyl cyanoacrylate
03

In context

Ulcer

2,021 studies on the registry are indexed under Ulcer; 216 are open to participants now.

This study's enrollment of 30 is below the median of 68 across 1,615 interventional studies indexed under Ulcer.

Browse Ulcer studies →

Lead sponsor

Suez Canal University is the lead sponsor of 157 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Apparently healthy cooperative children free from any systemic diseases that may predispose oral ulceration.

Development of pain/ulceration in the oral mucosa, surrounded by light red areola less than 1 cm. diameter.

Child with good oral hygiene. Parents willing to participate in the study and have a good likelihood of recall availability

Exclusion criteria

Exclusion Criteria:

Taking of drugs that may influence the pattern of oral ulceration Oral ulcerations with unknown etiology that are not traumatic in nature. Allergic or who have suffered adverse reactions to isobutyl cyanoacrylate gel or chlorhexidine gel

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Isobutyl cyanoacrylate

    Thin layers of a high viscosity isobutyl cyanoacrylate high viscous solution (periacryl 90 H.V) tissue adhesive will be applied on the ulcer site by using a pipette then rinsed with saline by using another pipette at least three times with an interval of at least 30 seconds once during the treatment episode to allow for complete polymerization, until achieving hemostasis

    Other: Isobutyl cyanoacrylate

  • Experimental
    Chlorhexidine 0.2%

    Application of chlorhexidine 0.2% (Elugel 2%) on finger tip then spread it on the ulcer site and gentle massaging twice daily for 9 days

    Other: Chlorhexidine (0.2%)

  • Placebo comparator
    normal saline

    will be treated with cotton soaked with normal saline on the ulcer site 5 times per day

    Other: Normal Saline (0.9% NaCl)

Interventions

  • OtherIsobutyl cyanoacrylate

    Thin layers of a high viscosity isobutyl cyanoacrylate high viscous solution Thin layers of a high viscosity isobutyl cyanoacrylate high viscous solution

    Also known as: periacryl 90 H.V

  • OtherChlorhexidine (0.2%)

    Chlorhexidine Digluconate 0.2%

    Also known as: Elugel 2%

  • OtherNormal Saline (0.9% NaCl)

    Sodium chloride 0.9%

    Also known as: Saline

06

What researchers measure

Primary outcomes

  1. pain assessment

    Assessment of pain will be performed using Children's International Mucositis Evaluation Scale (ChIMES)

    Time frame: 1st, 5th and 9th days

  2. Measurement of ulcer size

    Photographs of the ulcers will be recorded with a digital camera and Measurement of ulcer size by using a periodontal probe.

    Time frame: 1st, 5th and 9th days.

07

Study locations

1 site
  • Suez Canal University
    Ismailia, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06742983
Lead sponsor
Suez Canal University
Responsible party
Sponsor
First posted
Dec 19, 2024
Start date
Aug 4, 2023
Primary completion
Aug 4, 2024
Completion
Sep 20, 2024
Last update
Jan 22, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion